CD99 and melanoma: The second round immunophenotyping test showed PCK, CD99, OCT3/4, CD117, S100, and HMB45 were all negative while only Syna was positive, which can rule out metastatic carcinoma, germ cell tumor, melanoma, and primitive neuroectodermal tumor.